Aker BioMarine acquires IP & equipment from Acasti Pharma Inc. 31-Oct-2023 By Stephen Daniells Aker BioMarine ASA is consolidating intellectual property (IP) in the krill space, with the announcement that it has acquired krill-related patents, pre-clinical and clinical data, and processing equipment from Acasti Pharma Inc.